217 related articles for article (PubMed ID: 12133991)
1. Detection and induction of CTLs specific for SYT-SSX-derived peptides in HLA-A24(+) patients with synovial sarcoma.
Sato Y; Nabeta Y; Tsukahara T; Hirohashi Y; Syunsui R; Maeda A; Sahara H; Ikeda H; Torigoe T; Ichimiya S; Wada T; Yamashita T; Hiraga H; Kawai A; Ishii T; Araki N; Myoui A; Matsumoto S; Umeda T; Ishii S; Kawaguchi S; Sato N
J Immunol; 2002 Aug; 169(3):1611-8. PubMed ID: 12133991
[TBL] [Abstract][Full Text] [Related]
2. Crisscross CTL induction by SYT-SSX junction peptide and its HLA-A*2402 anchor substitute.
Ida K; Kawaguchi S; Sato Y; Tsukahara T; Nabeta Y; Sahara H; Ikeda H; Torigoe T; Ichimiya S; Kamiguchi K; Wada T; Nagoya S; Hiraga H; Kawai A; Ishii T; Araki N; Myoui A; Matsumoto S; Ozaki T; Yoshikawa H; Yamashita T; Sato N
J Immunol; 2004 Jul; 173(2):1436-43. PubMed ID: 15240740
[TBL] [Abstract][Full Text] [Related]
3. [Detection of SYT-SSX fusion gene in paraffin-embedded tissues and its clinicopathologic significance for synovial sarcoma].
Wei Y; Sun M; Zhu H; Xu Z; Wang J; Zhu X
Zhonghua Bing Li Xue Za Zhi; 2001 Dec; 30(6):426-30. PubMed ID: 11866984
[TBL] [Abstract][Full Text] [Related]
4. Phase I vaccination trial of SYT-SSX junction peptide in patients with disseminated synovial sarcoma.
Kawaguchi S; Wada T; Ida K; Sato Y; Nagoya S; Tsukahara T; Kimura S; Sahara H; Ikeda H; Shimozawa K; Asanuma H; Torigoe T; Hiraga H; Ishii T; Tatezaki SI; Sato N; Yamashita T
J Transl Med; 2005 Jan; 3(1):1. PubMed ID: 15647119
[TBL] [Abstract][Full Text] [Related]
5. [Detection and analysis of SYT-SSX fusion gene in synovial sarcoma].
Xu Z; Yang T; Wu B; Zhong H; Yang Z; Zhou B; Zhang C; Zheng J
Zhonghua Bing Li Xue Za Zhi; 2001 Dec; 30(6):431-3. PubMed ID: 11866985
[TBL] [Abstract][Full Text] [Related]
6. [Roles of immunohistochemistry and detection of SYT-SSX fusion gene in diagnosis of synovial sarcoma].
Sun Y; Sun BC; Zhao XL; Wang J; Chen J; Li XQ; Feng YM; Fang ZW; Hao XS
Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):480-4. PubMed ID: 17845763
[TBL] [Abstract][Full Text] [Related]
7. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma.
Kawai A; Woodruff J; Healey JH; Brennan MF; Antonescu CR; Ladanyi M
N Engl J Med; 1998 Jan; 338(3):153-60. PubMed ID: 9428816
[TBL] [Abstract][Full Text] [Related]
8. Detection of the SYT-SSX fusion transcripts in formaldehyde-fixed, paraffin-embedded tissue: a reverse transcription polymerase chain reaction amplification assay useful in the diagnosis of synovial sarcoma.
Lasota J; Jasinski M; Debiec-Rychter M; Szadowska A; Limon J; Miettinen M
Mod Pathol; 1998 Jul; 11(7):626-33. PubMed ID: 9688183
[TBL] [Abstract][Full Text] [Related]
9. Detection of SYT-SSX fusion transcripts in paraffin-embedded tissues of synovial sarcoma by reverse transcription-polymerase chain reaction.
Wei Y; Wang J; Zhu X; Shi D; Hisaoka M; Hashimoto H
Chin Med J (Engl); 2002 Jul; 115(7):1043-7. PubMed ID: 12150740
[TBL] [Abstract][Full Text] [Related]
10. SYT-SSX breakpoint peptide vaccines in patients with synovial sarcoma: a study from the Japanese Musculoskeletal Oncology Group.
Kawaguchi S; Tsukahara T; Ida K; Kimura S; Murase M; Kano M; Emori M; Nagoya S; Kaya M; Torigoe T; Ueda E; Takahashi A; Ishii T; Tatezaki S; Toguchida J; Tsuchiya H; Osanai T; Sugita T; Sugiura H; Ieguchi M; Ihara K; Hamada K; Kakizaki H; Morii T; Yasuda T; Tanizawa T; Ogose A; Yabe H; Yamashita T; Sato N; Wada T
Cancer Sci; 2012 Sep; 103(9):1625-30. PubMed ID: 22726592
[TBL] [Abstract][Full Text] [Related]
11. SYT-SSX is critical for cyclin D1 expression in synovial sarcoma cells: a gain of function of the t(X;18)(p11.2;q11.2) translocation.
Xie Y; Skytting B; Nilsson G; Gasbarri A; Haslam K; Bartolazzi A; Brodin B; Mandahl N; Larsson O
Cancer Res; 2002 Jul; 62(13):3861-7. PubMed ID: 12097301
[TBL] [Abstract][Full Text] [Related]
12. SYT-SSX fusion proteins in synovial sarcomas: detection and characterization with new antibodies.
Hashimoto N; Araki N; Yoshikawa H; Myoui A; Matsumine A; Kaneko M; Sonobe H; Ochi T
Cancer Lett; 2000 Feb; 149(1-2):31-6. PubMed ID: 10737705
[TBL] [Abstract][Full Text] [Related]
13. The SYT-SSX fusion protein down-regulates the cell proliferation regulator COM1 in t(x;18) synovial sarcoma.
Ishida M; Miyamoto M; Naitoh S; Tatsuda D; Hasegawa T; Nemoto T; Yokozeki H; Nishioka K; Matsukage A; Ohki M; Ohta T
Mol Cell Biol; 2007 Feb; 27(4):1348-55. PubMed ID: 17101797
[TBL] [Abstract][Full Text] [Related]
14. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.
Ladanyi M; Antonescu CR; Leung DH; Woodruff JM; Kawai A; Healey JH; Brennan MF; Bridge JA; Neff JR; Barr FG; Goldsmith JD; Brooks JS; Goldblum JR; Ali SZ; Shipley J; Cooper CS; Fisher C; Skytting B; Larsson O
Cancer Res; 2002 Jan; 62(1):135-40. PubMed ID: 11782370
[TBL] [Abstract][Full Text] [Related]
15. Vaccination using peptides spanning the SYT-SSX tumor-specific translocation.
Bloom JE; McNeel DG; Olson BM
Expert Rev Vaccines; 2012 Dec; 11(12):1401-4. PubMed ID: 23252384
[TBL] [Abstract][Full Text] [Related]
16. Identification of target genes of synovial sarcoma-associated fusion oncoprotein using human pluripotent stem cells.
Hayakawa K; Ikeya M; Fukuta M; Woltjen K; Tamaki S; Takahara N; Kato T; Sato S; Otsuka T; Toguchida J
Biochem Biophys Res Commun; 2013 Mar; 432(4):713-9. PubMed ID: 23313505
[TBL] [Abstract][Full Text] [Related]
17. Antigenicity of fusion proteins from sarcoma-associated chromosomal translocations.
Worley BS; van den Broeke LT; Goletz TJ; Pendleton CD; Daschbach EM; Thomas EK; Marincola FM; Helman LJ; Berzofsky JA
Cancer Res; 2001 Sep; 61(18):6868-75. PubMed ID: 11559563
[TBL] [Abstract][Full Text] [Related]
18. Detection of SYT-SSX fusion transcripts in synovial sarcoma by reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues.
Tsuji S; Hisaoka M; Morimitsu Y; Hashimoto H; Shimajiri S; Komiya S; Ushijima M; Nakamura T
Am J Pathol; 1998 Dec; 153(6):1807-12. PubMed ID: 9846971
[TBL] [Abstract][Full Text] [Related]
19. A wild-type sequence p53 peptide presented by HLA-A24 induces cytotoxic T lymphocytes that recognize squamous cell carcinomas of the head and neck.
Eura M; Chikamatsu K; Katsura F; Obata A; Sobao Y; Takiguchi M; Song Y; Appella E; Whiteside TL; DeLeo AB
Clin Cancer Res; 2000 Mar; 6(3):979-86. PubMed ID: 10741724
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma.
Clark J; Rocques PJ; Crew AJ; Gill S; Shipley J; Chan AM; Gusterson BA; Cooper CS
Nat Genet; 1994 Aug; 7(4):502-8. PubMed ID: 7951320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
